University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

The REal Life EVidence AssessmeNt Tool (RELEVANT) : development of a novel quality assurance asset to rate observational comparative effectiveness research studies

dc.contributor.authorCampbell, Jonathan D
dc.contributor.authorPerry, Robert
dc.contributor.authorPapadopoulos, Nikolaos G
dc.contributor.authorKrishnan, Jerry
dc.contributor.authorBrusselle, Guy
dc.contributor.authorChisholm, Alison
dc.contributor.authorBjermer, Leif
dc.contributor.authorThomas, Michael
dc.contributor.authorvan Ganse, Eric
dc.contributor.authorvan den Berge, Maarten
dc.contributor.authorQuint, Jennifer
dc.contributor.authorPrice, David
dc.contributor.authorRoche, Nicolas
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.date.accessioned2019-05-17T10:50:06Z
dc.date.available2019-05-17T10:50:06Z
dc.date.issued2019-03-27
dc.descriptionFunding for this research was provided by: European Academy of Allergy and Clinical Immunologyen
dc.description.statusPeer revieweden
dc.format.extent11
dc.format.extent901160
dc.identifier143973977
dc.identifierb69aebef-ea94-48e4-a497-b2e95919c032
dc.identifier30962876
dc.identifier85063421513
dc.identifier000462588600002
dc.identifier.citationCampbell, J D, Perry, R, Papadopoulos, N G, Krishnan, J, Brusselle, G, Chisholm, A, Bjermer, L, Thomas, M, van Ganse, E, van den Berge, M, Quint, J, Price, D & Roche, N 2019, 'The REal Life EVidence AssessmeNt Tool (RELEVANT) : development of a novel quality assurance asset to rate observational comparative effectiveness research studies', Clinical and Translational Allergy, vol. 9, no. 21, 21. https://doi.org/10.1186/s13601-019-0256-9en
dc.identifier.doi10.1186/s13601-019-0256-9
dc.identifier.iss21en
dc.identifier.issn2045-7022
dc.identifier.otherPubMedCentral: PMC6436213
dc.identifier.otherMendeley: ebe97ddc-461c-37f1-bef8-a5086a597d3b
dc.identifier.urihttp://hdl.handle.net/2164/12279
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85063421513&partnerID=8YFLogxKen
dc.identifier.urlhttp://www.mendeley.com/research/real-life-evidence-assessment-tool-relevant-development-novel-quality-assurance-asset-rate-observatien
dc.identifier.vol9en
dc.language.isoeng
dc.relation.ispartofClinical and Translational Allergyen
dc.subjectAsthmaen
dc.subjectComparative effectiveness research (CER)en
dc.subjectQualityen
dc.subjectObservational studiesen
dc.subjectAssessment toolen
dc.subjectRELEVANTen
dc.subjectBECLOMETASONEen
dc.subjectPOPULATIONen
dc.subjectDATABASEen
dc.subjectASTHMAen
dc.subjectWORLD RESEARCHen
dc.subjectR Medicine (General)en
dc.subjectPulmonary and Respiratory Medicineen
dc.subjectImmunology and Allergyen
dc.subjectImmunologyen
dc.subjectSupplementary Dataen
dc.subject.lccR1en
dc.titleThe REal Life EVidence AssessmeNt Tool (RELEVANT) : development of a novel quality assurance asset to rate observational comparative effectiveness research studiesen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
The_REal_Life_EVidence_AssessmeNt_Tool_.pdf
Size:
880.04 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
8.29 KB
Format:
Plain Text
Description: